101 related articles for article (PubMed ID: 21223753)
1. [Diagnosis and treatment of atypical adenomatous pulmonary hyperplasia in lungs].
Zhang Y; Zhi XY; Chen L; Wang DY; Li Y; Wang RT; Hu M; Liu L; Qian K
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(47):3355-8. PubMed ID: 21223753
[TBL] [Abstract][Full Text] [Related]
2. The association between atypical adenomatous hyperplasia and primary lung cancer.
Chapman AD; Kerr KM
Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
[TBL] [Abstract][Full Text] [Related]
3. Monoclonality of atypical adenomatous hyperplasia of the lung.
Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
6. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
Kerr KM; Carey FA; King G; Lamb D
J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
[TBL] [Abstract][Full Text] [Related]
7. [Atypical adenomatous hyperplasia of the lung].
Paklina OV; Galil-Ogly GA; Bershchanskaia AM; Alipchenko LA
Arkh Patol; 2000; 62(3):21-4. PubMed ID: 10897432
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
9. Precursor lesions of adenocarcinoma lung--two case reports.
Jain D; Joshi K; Jindal SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):399-402. PubMed ID: 16761769
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
11. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases.
Sterner DJ; Mori M; Roggli VL; Fraire AE
Mod Pathol; 1997 May; 10(5):469-73. PubMed ID: 9160312
[TBL] [Abstract][Full Text] [Related]
13. CT findings of atypical adenomatous hyperplasia in the lung.
Park CM; Goo JM; Lee HJ; Lee CH; Kim HC; Chung DH; Im JG
Korean J Radiol; 2006; 7(2):80-6. PubMed ID: 16799268
[TBL] [Abstract][Full Text] [Related]
14. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
16. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
17. [Atypical adenomatous hyperplasia].
Takaoka K
Ryoikibetsu Shokogun Shirizu; 1994; (4):20-2. PubMed ID: 8007130
[No Abstract] [Full Text] [Related]
18. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
19. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
[TBL] [Abstract][Full Text] [Related]
20. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]